rood blauwe elepsis logo Belegger.nl

ACCSYS TECHNOLOGIES PLC Terug naar discussie overzicht

Hoogste koers in 2013

78 Posts
Pagina: «« 1 2 3 4 »» | Laatste | Omlaag ↓
  1. [verwijderd] 19 april 2013 20:21
    Weer 2 keer 600000 buiten de beurs om verhandeld. Men wil niet dat de koers omhoog gaat en handelt gewoon op 0,15.
    Time/Date Price Volume Trade Value Type Buy/Sell 15:54:48 19-Apr-2013 0
  2. drulletje drie 2 mei 2013 08:51
    AMSTERDAM (AFN) - Accsys Technologies, ontwikkelaar van houtproducten, heeft de omzet in het jaar dat eindigde op 31 maart met 25 procent zien stijgen tot 18,8 miljoen euro. Dat meldde het bedrijf donderdag.
    De onderneming denkt dat de omzet ook in de toekomst zal blijven groeien, maar de snelheid daarvan is moeilijk aan te geven. De omzet uit Accoya, het belangrijkste product van Accsys, steeg in de verslagperiode met 45 procent tot 16,4 miljoen euro. Accsys is naar eigen zeggen ,,op koers'' om het langetermijndoel van winstgevendheid te behalen.
  3. drulletje drie 2 mei 2013 09:51
    Accsys boekt 25% meer omzet, verwacht aanhoudende omzetgroei

    Door Levien de Feijter
    Van DOW JONES NIEUWSDIENST

    AMSTERDAM (Dow Jones)--Accsys Technologies plc (AXS.LN) heeft in het afgelopen gebroken boekjaar een kwart meer omzet behaald en verwacht dat de omzetgroei zal aanhouden.
    De onderneming die technologie ontwikkelt voor de verduurzaming van hout meldt donderdag in een voorlopige trading update dat het tempo van de verwachte aanhoudende omzetgroei moeilijk te voorspellen is.
    In het jaar dat eindigde op 31 maart nam de omzet toe met 25% tot EUR18,8 miljoen van EUR15,0 miljoen een jaar eerder. De inkomsten uit de verkoop van Accoya hout liep met 45% op tot EUR16,4 miljoen.
    De inkomsten uit de verkoop van licenties, waar de onderneming in de toekomst vooral op mikt, bedroeg EUR0,6 miljoen. Dit bedrag werd gedurende de halfjaarcijfers ook al gemeld, wat er op wijst dat in de tweede helft er geen inkomsten uit licenties zijn bijgekomen.
    De kaspositie was eind maart EUR20,5 miljoen, ten opzichte van EUR20,5 miljoen eind 2012.
    Accsys maakt geen winstcijfers bekend, maar geeft wel aan dat een positieve brutomarge is bereikt. De onderneming stelt goed op weg te zijn met de lange termijn doelstellingen om winstgevend te worden. De gesprekken met Solvay-Rhodia een licentie-overeenkomst blijven lopen en Accsys verwacht dat de momenteel voorlopige overeenkomst dit jaar nog definitief zal worden.
    Omstreeks 9.40 uur noteert het aandeel 6,7% hoger op EUR0,16.

    - Door Levien de Feijter; Dow Jones Newswires; +31 20 571 52 00; levien.defeijter@dowjones.com
  4. drulletje drie 2 mei 2013 11:09
    MARKET TALK: Accsys omzetgroei sterk - SNS

    AMSTERDAM (Dow Jones)--Accsys (AXS.LN) heeft een sterke omzetgroei bekendgemaakt over het gebroken boekjaar dat op 31 maart eindigde, volgens SNS Securities. De omzet steeg met 25% tot EUR18,8 miljoen en de inkomsten uit de verkoop van Acccys's belangrijkste product, Accoya hout, stegen met 45%. SNS-analist Johan van den Hooven vindt ook de voortgang met Solvay-Rhodia over een licentieovereenkomst bemoedigend, aangezien Accsys erop rekent dat aan het einde van dit jaar een definitieve overeenkomst kan worden bereikt. Het advies is buy met een koersdoel van EUR0,18. Omstreeks 10.50 uur noteert het aandeel 6,7% hoger op EUR0,16. (LDF)

    Dow Jones Nieuwsdienst: +31-20-5715200; amsterdam@dowjones.com
  5. alida1 2 mei 2013 11:46
    quote:

    drulletje drie schreef op 2 mei 2013 11:09:

    MARKET TALK: Accsys omzetgroei sterk - SNS

    AMSTERDAM (Dow Jones)--Accsys (AXS.LN) heeft een sterke omzetgroei bekendgemaakt over het gebroken boekjaar dat op 31 maart eindigde, volgens SNS Securities. De omzet steeg met 25% tot EUR18,8 miljoen en de inkomsten uit de verkoop van Acccys's belangrijkste product, Accoya hout, stegen met 45%. SNS-analist Johan van den Hooven vindt ook de voortgang met Solvay-Rhodia over een licentieovereenkomst bemoedigend, aangezien Accsys erop rekent dat aan het einde van dit jaar een definitieve overeenkomst kan worden bereikt. Het advies is buy met een koersdoel van EUR0,18. Omstreeks 10.50 uur noteert het aandeel 6,7% hoger op EUR0,16. (LDF)

    Dow Jones Nieuwsdienst: +31-20-5715200; amsterdam@dowjones.com
    Gewoon hele goede berichten. Er zijn weinig mensen die echt op de lange termijn denken. anders zou de koers wel omhoog gaan. Dit aandeel is echt pareltje voor de toekomst.
  6. drulletje drie 2 mei 2013 11:51
    TRANSACTIES
    Tijd Volume Prijs
    11:49:40 50.000 0,160
    11:49:34 200.000 0,160
    11:49:18 100.000 0,160
    11:49:13 5.000 0,160
    11:48:43 45.000 0,160
    11:48:36 150.000 0,160
    11:48:26 50.000 0,160
    11:48:14 100.000 0,160
    11:48:01 100.000 0,160
    11:47:58 80.000 0,160
    11:19:58 20.000 0,160
    10:39:44 90.589 0,160
    10:04:46 9.411 0,160
    09:00:24 1.000 0,160
  7. [verwijderd] 2 mei 2013 17:17
    Het oude verhaal, omzet gestegen maar geringe brutowinstmarge en licentie komt nog wel eens een keer. Ook de koers van 0,16 komt mij bekend voor.
  8. [verwijderd] 6 mei 2013 10:39
    Regulatory Story deel 1
    Go to market news section
    Company Accsys Technologies PLC
    TIDM AXS
    Headline Trading update
    Released 07:08 02-May-2013
    Number 8302D07

    RNS Number : 8302D
    Accsys Technologies PLC
    02 May 2013

    ?



    AIM: AXS
    NYSE Euronext Amsterdam: AXS
    2 May 2013

    ACCSYS TECHNOLOGIES PLC
    ("Accsys" or the "Company")

    Trading update

    Accsys today issues a trading update for the year to 31 March 2013 (based on unaudited figures). Key highlights include:

    · Total revenue increased by 25% to €18.8m for the year ended 31 March 2013 (2012: €15.0m);

    · Revenue from sales to Accoya® customers increased by 45% for the year ended 31 March 2013 to €16.4m (2012: €11.3m);

    · Positive gross margin achieved at the group level for the year ended 31 March 2013;

    · Continue to expect our Arnhem manufacturing plant to reach at least 50% capacity utilisation and hence be EBITDA positive in the current financial year;

    · Continuing progress with Solvay-Rhodia towards a fully effective licence agreement which we expect to become unconditional later in 2013;

    · New Accoya® decking product retail trial launched by Solvay-Rhodia in over 40 outlets in Europe;

    · Total of 42 Accoya® distributor and agency agreements now in place (an increase of three since February) covering most of Europe, Australia, Canada, Chile, China, India, Mexico, Morocco, New Zealand, parts of South-East Asia and the USA;

    · Tricoya Technologies Limited ('TTL'), the joint venture with Ineos, continues to make progress, developing both new and existing Tricoya® licence opportunities including the signing of a Heads of Terms in December 2012 for a conditional licence agreement with Medite;

    · Further industry recognition:

    o Medite Tricoya® won Product of the Year at the Sustain Magazine Awards for Sustainability, Business and the Built Environment; and

    o Accoya® window frames have been found to be carbon negative over their lifetime; and

    · Net cash balance of €20.5m at 31 March 2013 (December 2012: €21.2m).

    Financial results (unaudited)
    Total revenue for the year ended 31 March 2013 increased by 25% to €18.8m (2012: €15.0). In the same period, Accoya® revenue increased by 45%, excluding sales to Medite for the manufacture of Tricoya, to €16.4m (2012: €11.3m), noting a substantial volume was sold to Medite in the second half of the previous financial year to enable them to build up initial stocks of Medite Tricoya. Total revenue also included €0.6m of licence income which had been recorded in the first half of the year. We expect revenue to continue to grow however this rate of growth is likely to remain difficult to predict from one period to another.
    Net cash balance as at 31 March 2013 of €20.5m represents a decrease of €0.7m since 31 December 2012. The decrease is after taking account of €1.7m received in February 2013 following the completion of the second part of the sale and leaseback of the land in Arnhem and also reflects the operating loss in the period, the first cash investment into TTL, capital expenditure (including development costs) and changes to other working capital balances. Cash out-flow from operating activities before changes in working capital has decreased significantly in the year ended March 2013 compared to the prior year and this trend is expected to continue.
    Trading update
    Accsys continues to make progress towards achieving its longer term objective of achieving profitability.
    Following the delivery of the first stages of the engineering Process Design Package to Solvay-Rhodia in November 2012, Accsys and Solvay-Rhodia continue to work towards completing the full Process Design Package which will enable the detailed engineering to be completed. Our respective sales teams continue to develop the market and we have been very pleased that Solvay-Rhodia has launched a trial of a new Accoya® decking product in over 40 retail outlets in Europe. We expect this collaboration to increase and we continue to expect the licence agreement to become unconditional following the approval of Solvay-Rhodia's board of directors later in 2013.
    Revenue from Accoya® customers increased by 45% in the year to 31 March 2013 compared to last year reflecting continuing strong growth in demand. We expect growth to continue and have been pleased to sign a number of new distributors or sales agents over the last few months including in Germany, Austria, Czech Republic, Italy, Denmark and Iceland.
    We have recently announced Accoya® price increases in all regions which will become effective over the first quarter of 2013/14 financial year. While the price increase is in part attributable to increasing raw material costs, taken together with increased sales volumes, we expect profitability to improve such that we continue to expect the Arnhem manufacturing facility to achieve an EBITDA positive level at 50% of its current capacity in the current year; a level which also indicates the potential returns a prospective licensee may be able to generate.
  9. [verwijderd] 6 mei 2013 10:40
    deel 2
    Accoya® and Tricoya® continue to receive industry recognition of their superior qualities: An updated analysis by leading climate change consultancy Verco, has shown that Accoya's carbon footprint significantly outperforms most other building materials, including a wide range of sustainably sourced hardwoods. Further analysis by the Delft University of Technology revealed that Accoya® window frames are now classified as carbon negative over their lifetime cycle. Medite Tricoya® won Product of the Year at the Sustain Magazine Awards for Sustainability, Business and the Built Environment based on its combined innovation and transparent sustainability.
    TTL continues to make progress and is working towards agreeing a full conditional licence agreement with Medite for the manufacture of Tricoya, following the signing of a Heads of Terms in December 2012.
    Accsys and TTL continue to develop a number of new and existing potential Accoya® and Tricoya® licence opportunities respectively, with counterparties whose combined existing total wood product manufacturing or processing capacity is in excess of 10 million m3 per annum. While these discussions remain ongoing, the complex nature and investment required by a licensee, means that the timing and certainty of their completion remains difficult to predict.
    The date of the full preliminary announcement of the financial results for the year ended 31 March 2013 and the related webcast is expected to be announced in June.
    Commenting on the trading update released today, Paul Clegg, CEO of Accsys Technologies PLC said: "We are pleased by the growth in our underlying Accoya® sales and generation of positive gross margin which we have achieved despite continuing difficult economic conditions impacting the construction industry. The on-going recognition of the many superior benefits of our products, combined with increased sales recorded by both existing as well as new distributors, give us confidence that growth will continue. The progress with the Solvay-Rhodia licence agreement is encouraging and the on-going development of both new and existing licensing opportunities continues to provide confidence concerning our longer term objective of achieving profitability."
    Ends
    For further information, please contact:

    Accsys Technologies PLC
    Paul Clegg, CEO
    Hans Pauli, COO
    Will Rudge, FD

    via Blythe Weigh Communications
    Numis Securities
    Nominated Adviser: Oliver Cardigan
    Corporate Broking: Christopher Wilkinson
    Ben Stoop
    +44 (0)20 7260 1000

    Blythe Weigh

    Paul Weigh
    Tim Blythe

    +44 (0)20 7138 3204
    +44 (0) 7989 129658
    +44 (0) 7816 924626


    SPJ Financial & Corporate Communication

    Frank Neervoort

    +31 681734236


    Notes to editors:

    Accsys Technologies PLC(www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

    Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

    Tricoya® Wood Elements(www.tricoya.com) are produced using Accsys' proprietary technology for the acetylation of wood chips, and particles for use in the fabrication of wood based composites, including panel products. These composites demonstrate enhanced durability and dimensional stability which allow them to be used in a variety of applications that were once limited to solid wood or man-made products. Exploitation of Accsys' proprietary technology relating to Tricoya® Wood Elements is carried out through Tricoya Technologies Limited, a joint venture between Accsys and INEOS Industries Holdings Limited. Tricoya® Wood Elements are lauded as the first major innovation in the wood composites industry in more than 30 years.

    Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. When carried out to a sufficient level throughout the wood, this process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.


    Accsys Technologies is the trading name of Titan Wood Limited. ACCOYA®, TRICOYA® and the Trimarque Device are registered trademarks owned by Titan Wood Limited ("TWL"), a wholly owned subsidiary of Accsys Technologies PLC, and may not be used or reproduced without written permission from TWL, or in the case of the Tricoya® registered trademark, from Tricoya Technologies Limited, a joint venture between TWL and INEOS Industries Holdings Limited with exclusive rights to exploit the Tricoya® brand.

  10. [verwijderd] 6 mei 2013 17:46
    2 May 2013

    ACCSYS TECHNOLOGIES PLC
    ("Accsys" or the "Company")

    Trading update

    Accsys today issues a trading update for the year to 31 March 2013 (based on unaudited figures). Key highlights include:

    · Total revenue increased by 25% to €18.8m for the year ended 31 March 2013 (2012: €15.0m);

    · Revenue from sales to Accoya® customers increased by 45% for the year ended 31 March 2013 to €16.4m (2012: €11.3m);

    · Positive gross margin achieved at the group level for the year ended 31 March 2013;

    · Continue to expect our Arnhem manufacturing plant to reach at least 50% capacity utilisation and hence be EBITDA positive in the current financial year;

    · Continuing progress with Solvay-Rhodia towards a fully effective licence agreement which we expect to become unconditional later in 2013;

    · New Accoya® decking product retail trial launched by Solvay-Rhodia in over 40 outlets in Europe;

    · Total of 42 Accoya® distributor and agency agreements now in place (an increase of three since February) covering most of Europe, Australia, Canada, Chile, China, India, Mexico, Morocco, New Zealand, parts of South-East Asia and the USA;

    · Tricoya Technologies Limited ('TTL'), the joint venture with Ineos, continues to make progress, developing both new and existing Tricoya® licence opportunities including the signing of a Heads of Terms in December 2012 for a conditional licence agreement with Medite;

    · Further industry recognition:

    o Medite Tricoya® won Product of the Year at the Sustain Magazine Awards for Sustainability, Business and the Built Environment; and

    o Accoya® window frames have been found to be carbon negative over their lifetime; and

    · Net cash balance of €20.5m at 31 March 2013 (December 2012: €21.2m).
  11. alida1 6 mei 2013 22:02
    X.blue, bedankt! het fundament wordt elke keer wat beter. minder verliezen, meer perspectief. Een lange weg maar hij gaat omhoog.
  12. [verwijderd] 14 mei 2013 17:18
    Een typisch daytradersaandeel, een centje winst en wegwezen. Voor meer zal een structurele resultatenverbetering nodig zijn en een licentie. Dat laatste had al gebeurd moeten zijn, aan eindeloze beloftes heb je niet veel.
78 Posts
Pagina: «« 1 2 3 4 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.012
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.548
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.589
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.732
Aedifica 3 903
Aegon 3.258 322.688
AFC Ajax 538 7.087
Affimed NV 2 6.295
ageas 5.844 109.887
Agfa-Gevaert 14 2.049
Ahold 3.538 74.331
Air France - KLM 1.025 35.024
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.701
Allfunds Group 4 1.469
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 405
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.821
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.941
AMG 971 133.211
AMS 3 73
Amsterdam Commodities 305 6.687
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.975
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.767
Arcelor Mittal 2.033 320.667
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.296
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.089
ASML 1.766 106.525
ASR Nederland 21 4.452
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.647
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392